Decathlon invests in diagnostics firm Amprion Inc

AI Summary

Decathlon Capital Partners is investing in Amprion Inc to expand diagnostic testing capacities for neurodegenerative diseases including Parkinson's, Lewy body dementia, and Alzheimer's. This investment aims to support advancements in health technology diagnostics.

Decathlon Capital Partners will support the expansion of Amprion's diagnostic testing capacity for neurodegenerative diseases such as Parkinson's disease, Lewy body dementia, and Alzheimer's disease. The post Decathlon invests in diagnostics firm Amprion Inc appeared first on PE Hub.